The stock of Soleno Therapeutics Inc (SLNO) has gone up by 8.24% for the week, with a 14.48% rise in the past month and a 68.71% rise in the past quarter. The volatility ratio for the week is 1.32%, and the volatility levels for the past 30 days are 1.96% for SLNO. The simple moving average for the past 20 days is 8.52% for SLNO’s stock, with a 47.82% simple moving average for the past 200 days.
Is It Worth Investing in Soleno Therapeutics Inc (NASDAQ: SLNO) Right Now?
The 36-month beta value for SLNO is at -2.67. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 3 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SLNO is 41.75M, and currently, shorts hold a 9.55% of that float. The average trading volume for SLNO on June 24, 2025 was 1.36M shares.
SLNO) stock’s latest price update
Soleno Therapeutics Inc (NASDAQ: SLNO)’s stock price has gone rise by 1077322 in comparison to its previous close of 81.42, however, the company has experienced a 8.24% increase in its stock price over the last five trading days. globenewswire.com reported 2025-06-20 that Conference is the first-ever international meeting jointly hosted by the Prader-Willi Syndrome Association | USA, the Foundation for Prader-Willi Research, and the International Prader-Willi Syndrome Organisation Conference is the first-ever international meeting jointly hosted by the Prader-Willi Syndrome Association | USA, the Foundation for Prader-Willi Research, and the International Prader-Willi Syndrome Organisation
Analysts’ Opinion of SLNO
Many brokerage firms have already submitted their reports for SLNO stocks, with TD Cowen repeating the rating for SLNO by listing it as a “Buy.” The predicted price for SLNO in the upcoming period, according to TD Cowen is $110 based on the research report published on June 23, 2025 of the current year 2025.
Stifel, on the other hand, stated in their research note that they expect to see SLNO reach a price target of $74. The rating they have provided for SLNO stocks is “Buy” according to the report published on March 05th, 2025.
Stifel gave a rating of “Buy” to SLNO, setting the target price at $74 in the report published on December 02nd of the previous year.
SLNO Trading at 12.26% from the 50-Day Moving Average
After a stumble in the market that brought SLNO to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 3.66% of gains for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SLNO starting from Hirano Patricia C, who sale 3,782 shares at the price of $70.11 back on Apr 01 ’25. After this action, Hirano Patricia C now owns 27,036 shares of Soleno Therapeutics Inc, valued at $265,156 using the latest closing price.
Stock Fundamentals for SLNO
The total capital return value is set at -0.54. Equity return is now at value -105.54, with -81.42 for asset returns.
Based on Soleno Therapeutics Inc (SLNO), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -30.2. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 143.86.
Currently, EBITDA for the company is -173.63 million with net debt to EBITDA at 0.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 19.64.
Conclusion
In conclusion, Soleno Therapeutics Inc (SLNO) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
